BioCelerate Newsletter – November 2020 Learn More SEND Implementation for Cross-Study Analysis Initiative Publishes New Manuscript: Leveraging the Value of CDISC SEND Datasets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals Learn More BioCelerate Newsletter – April 2021 Learn More BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA Learn More Harmonization of SEND Implementation to Enable Historical Control Data Analysis, the Recommendations for Populating Control Type (TCNTRL) with CDISC SEND Controlled Terminology White Paper was published on the PHUSE website Learn More BioCelerate Newsletter – November 2021 Learn More Janice Chang Named New CEO of TransCelerate and BioCelerate Learn More Leveraging CDISC SEND Data Sets for Study Analyses Learn More TransCelerate and BioCelerate Launch New Technology Platform to Enable R&D Data Sharing Learn More BioCelerate Releases V1.1 of the Nonclinical Protocol Template for Repeat-Dose Toxicology Studies Learn More
SEND Implementation for Cross-Study Analysis Initiative Publishes New Manuscript: Leveraging the Value of CDISC SEND Datasets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals Learn More
BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA Learn More
Harmonization of SEND Implementation to Enable Historical Control Data Analysis, the Recommendations for Populating Control Type (TCNTRL) with CDISC SEND Controlled Terminology White Paper was published on the PHUSE website Learn More
BioCelerate Releases V1.1 of the Nonclinical Protocol Template for Repeat-Dose Toxicology Studies Learn More
